-
Mashup Score: 8Treating HER2-Amplified mCRC - 28 day(s) ago
A video from Ibrahim Sahin, posted on Mar 22, 2024.
Source: www.vumedi.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 16Treating BRAF-Mutated mCRC - 1 month(s) ago
A video from Ibrahim Sahin, posted on Mar 15, 2024.
Source: www.vumedi.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Treating KRAS-Mutated mCRC - 2 month(s) ago
Treating KRAS-Mutated mCRC
Source: www.vumedi.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7Early-Onset CRC: A New Epidemic With Knowns and Unknowns - 2 month(s) ago
Early-Onset CRC: A New Epidemic With Knowns and Unknowns
Source: www.vumedi.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 33The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review - 3 month(s) ago
This review evaluates the efficacy of immune checkpoint inhibitors in ICIs in microsatellite stable colorectal cancer and explores promising combination strateg
Source: academic.oup.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 32The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review - 3 month(s) ago
This review evaluates the efficacy of immune checkpoint inhibitors in ICIs in microsatellite stable colorectal cancer and explores promising combination strateg
Source: academic.oup.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 1Ibrahim Halil Sahin: A common question I received after my tweet on the PEGASUS trial... - Oncodaily | Oncology News, Insights, Stories - 5 month(s) ago
Source: Ibrahim Halil Sahin/X
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2
The US Food and Drug Administration (FDA) approved pembrolizumab for patients with unresectable or metastatic solid tumors with tumor mutational burden (TMB) of ≥ 10 mutations/megabase. However, th…
Source: www.tandfonline.comCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 6A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation - Full Text View - ClinicalTrials.gov - 1 year(s) ago
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation – Full Text View.
Source: clinicaltrials.govCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 5
Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10) – Full Text View.
Source: clinicaltrials.govCategories: Hem/Oncs, Latest HeadlinesTweet
For more 👇 https://t.co/Qtw9qOgsR5